About

Amanda Bogle is an associate in the Corporate Practice Group in the firm's Chicago office and a member of the Healthcare Team.

Latest Post

Preparing for HRSA’s 340B Rebate Model Pilot Program and the Beacon Platform

November 19, 2025

On October 30, HRSA announced that it had selected eight drug manufacturers to participate in its 340B Rebate Model Pilot Program, spanning 10 drugs representing a range of widely used therapies. These include:

Continue Reading Preparing for HRSA’s 340B Rebate Model Pilot Program and the Beacon Platform

HRSA’s 340B Rebate Pilot Program: Industry Debates, Congressional Response, and Program Implications

September 18, 2025

HRSA Launches and Seeks Comments on 340B Rebate Model Pilot Program

August 7, 2025

HRSA Announces New Requirements for FQHCs to Provide Insulin and Epinephrine at or below 340B Price

June 26, 2025

Federal District Court Upholds Authority of HHS to Pre-Approve 340B Rebate Programs; HRSA Submits Proposed 340B Rebate Guidance

June 4, 2025

FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies

March 21, 2025

California Votes to Impose 340B Spending Restrictions on Targeted 340B Providers

November 13, 2024

About

Amanda Bogle is an associate in the Corporate Practice Group in the firm's Chicago office and a member of the Healthcare Team.

Connect:

Subscribe:

Blogs

Healthcare Law Blog

About

Latest Post

More Posts

About